Influence of acute glycaemic level on measures of myocardial infarction in non-diabetic pigs

Scandinavian Cardiovascular Journal

Volumn 49, Issue 6, 2015, Pages 376-382

  Diemar, Sarah S ^a,b   Sejling, Anne Sophie ^a,c   Iversen, Kasper K ^d   Engstrøm, Thomas ^e   Honge, Jesper L ^f   Tønder, Niels ^a   Vejlstrup, Niels ^d   Idorn, Manja ^d   Ekström, Kathrine ^a,b   Pedersen Bjergaard, Ulrik ^a,b   Thorsteinsson, Birger ^a,b   Dalsgaard, Morten ^d  

^a HILLERØD HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e University of Copenhagen   (Denmark)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cardiovascular disease; Coronary Artery Disease; Diabetes Mellitus; Hypoglycaemia; Myocardial infarction

Indexed keywords

GLUCOSE; TROPONIN T; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL PIG; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE FIBRILLATION; HYPERGLYCEMIA; HYPOGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ANIMAL; BLOOD; CARDIAC MUSCLE; DISEASE MODEL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PIG; REPERFUSION INJURY; RISK FACTOR; TIME FACTOR;

ANIMALS; BIOMARKERS; BLOOD GLUCOSE; DISEASE MODELS, ANIMAL; FEMALE; HYPERGLYCEMIA; HYPOGLYCEMIA; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RISK FACTORS; SWINE; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 84942293949     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2015.1085079     Document Type: Article

References (29)

1. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-61.
2. Mellbin LG, Malmberg K, Norhammar A, Wedel H, Ryden L. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J. 2008;29:166-76.
3. Graveling AJ, Frier BM. Review: Does hypoglycaemia cause cardiovascular events? Brit Jof Diabetes and Vascular Disease. 2010;10:5-13.
4. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
5. Gerstein HC, Miller ME, Byington RP, Goff DC, Jr., Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358: 2545-59.
6. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-89.
7. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560-72.
8. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129-39.
9. Yakubovich N, Gerstein HC. Serious cardiovascular outcomes in diabetes: the role of hypoglycemia. Circulation. 2011;123:342-8.
10. Libby P, Maroko PR, Braunwald E. The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation. 1975;51: 621-6.
11. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diab Care. 2010;33:1389-94.
12. Reno CM, Daphna-Iken D, Chen YS, VanderWeele J, Jethi K, Fisher SJ. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes. 2013;62:3570-81.
13. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008;24:353-63.
14. Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diab Care. 2003; 26:1485-9.
15. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94:730-6.
16. Orn S, Manhenke C, Anand IS, Squire I, Nagel E, Edvardsen T, et al. Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. Am J Cardiol. 2007;99:1109-14.
17. Suzuki Y, Lyons JK, Yeung AC, Ikeno F. In vivo porcine model of reperfused myocardial infarction: in situ double staining to measure precise infarct area/area at risk. Catheter Cardiovasc Interv. 2008;71:100-7.
18. Naslund U, Haggmark S, Johansson G, Marklund SL, Reiz S. Aclosed-chest myocardial occlusion-reperfusion model in the pig: techniques, morbidity and mortality. Eur Heart J. 1992;13:1282-9.
19. Krombach GA, Kinzel S, Mahnken AH, Gunther RW, Buecker A. Minimally invasive close-chest method for creating reperfused or occlusive myocardial infarction in swine. Invest Radiol. 2005;40:14-8.
20. Hirakawa Y, Arima H, Zoungas S, Ninomiya T, Cooper M, Hamet P, et al. Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and allcause mortality in type 2 diabetes: the ADVANCE trial. Diab Care. 2014;37:2359-65.
21. Horvath EM, Benko R, Kiss L, Muranyi M, Pek T, Fekete K, et al. Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia. 2009;52:952-61.
22. Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP, et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46:178-80.
23. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J. 2005;26:1255-61.
24. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.
25. Goyal A, Mehta SR, Diaz R, Gerstein HC, Afzal R, Xavier D, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation. 2009;120:2429-37.
26. Lonborg J, Vejlstrup N, Kelbaek H, Nepper-Christensen L, Jorgensen E, Helqvist S, et al. Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study. Diabetes. 2014;63: 2474-85.
27. Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410-8.
28. Vivaldi MT, Kloner RA, Schoen FJ. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol. 1985;121:522-30.
29. Bodi V, Sanchis J, Mainar L, Chorro FJ, Nunez J, Monmeneu JV, et al. Right ventricular involvement in anterior myocardial infarction: a translational approach. Cardiovasc Res. 2010;87:601-8.